Marcum Wealth LLC Increases Stock Position in Colgate-Palmolive (NYSE:CL)

Marcum Wealth LLC grew its stake in Colgate-Palmolive (NYSE:CL) by 8.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,728 shares of the company’s stock after acquiring an additional 282 shares during the period. Marcum Wealth LLC’s holdings in Colgate-Palmolive were worth $339,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wealthspire Advisors LLC grew its position in Colgate-Palmolive by 3.0% in the 2nd quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after acquiring an additional 111 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of Colgate-Palmolive by 2.5% in the second quarter. Oppenheimer Asset Management Inc. now owns 27,860 shares of the company’s stock valued at $2,704,000 after purchasing an additional 678 shares during the period. Envestnet Asset Management Inc. grew its holdings in shares of Colgate-Palmolive by 16.2% in the second quarter. Envestnet Asset Management Inc. now owns 459,445 shares of the company’s stock valued at $44,585,000 after purchasing an additional 64,123 shares in the last quarter. Angeles Investment Advisors LLC purchased a new stake in Colgate-Palmolive during the 2nd quarter worth approximately $242,000. Finally, Dimensional Fund Advisors LP increased its stake in Colgate-Palmolive by 19.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,503,450 shares of the company’s stock worth $340,006,000 after buying an additional 565,524 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 0.7 %

Colgate-Palmolive stock opened at $87.73 on Wednesday. The stock has a 50-day simple moving average of $92.36 and a 200-day simple moving average of $97.92. The company has a market capitalization of $71.68 billion, a P/E ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on CL shares. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Finally, JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $103.63.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.